Peregrine Pharmaceuticals reported $30.46M in Trade Creditors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Agenus AGEN:US $ 41M 6.46M
Amgen AMGN:US $ 1256M 147M
Bristol Myers Squibb BMY:US $ 2882M 62M
Celldex Therapeutics CLDX:US $ 0.9M 0.12M
Chemocentryx CCXI:US $ 7.59M 2.17M
Eli Lilly And LLY:US $ 1659.3M 226M
Intrexon XON:US $ 2.67M 1.75M
Karyopharm Therapeutics KPTI:US $ 1.69M 1.75M
Macrogenics MGNX:US $ 2.61M 1.12M
Mannkind MNKD:US $ 7.82M 0.88M
Minerva Neurosciences NERV:US $ 1.52M 0.07M
Newlink Genetics NLNK:US 854K 945K
Novartis NOVN:VX 4.97B 114M
Novavax NVAX:US $ 386.49M 251.36M
Peregrine Pharmaceuticals PPHM:US $ 30.46M 20.96M
Repligen RGEN:US $ 40.38M 2.1M
Xencor XNCR:US $ 15.75M 3.84M